Clinical Trial Update: Evaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to Immediate-release Nicotinic Acid and Placebo in Healthy Subjects and Subjects With Prediabetes [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and pharmacokinetics of oral controlled-ileal-release nicotinic acid (CIR-NA) versus immediate-release nicotinic acid and placeb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• CIR-NA (nicotinic acid)
• Immediate-release nicotinic acid (nicotinic acid)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Safety Issues, Pharmacokinetic | Phase 1 | Status: COMPLETED